SCHEMBL5834796

SCHEMBL5834796

CCOC(=O)NC1(C(=O)Nc2ccc(N(CC)CC)cc2)CCc2ccccc2C1

nearest known ligand 0.82

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GHSR Q92847 6/20 0.82
KCNH2 Q12809 1/20 0.45
MAPT P10636 5/20 0.43
NPY1R P25929 1/20 0.43
NPY2R P49146 1/20 0.43
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
NPC1 O15118 3/20 0.43
RAB9A P51151 3/20 0.43
NOX1 Q9Y5S8 1/20 0.43
SMN1; SMN2 Q16637 4/20 0.39
GFER P55789 1/20 0.39
LMNA P02545 2/20 0.39
TSHR P16473 2/20 0.39
POLB P06746 2/20 0.39
USP2 O75604 1/20 0.39
HCRTR1 O43613 1/20 0.39
NPSR1 Q6W5P4 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5835377 0.92 GHSR (0.79) GHSRKCNH2MAPTNPY1RNPY2R
SCHEMBL5835502 0.90 GHSR (0.77) GHSRKCNH2MAPTNPY1RNPY2R
SCHEMBL5836112 0.90 GHSR (0.77) GHSRKCNH2MAPTNPY1RNPY2R
SCHEMBL5835251 0.90 GHSR (0.77) GHSRKCNH2MAPTNPY1RNPY2R
SCHEMBL5835538 0.90 GHSR (0.77) GHSRKCNH2MAPTMEN1KMT2A
SCHEMBL5835606 0.90 GHSR (0.77) GHSRKCNH2MAPTMEN1KMT2A
SCHEMBL5835139 0.90 GHSR (1.00) GHSRKCNH2MAPTNPY1RNPY2R
SCHEMBL5835307 0.90 GHSR (0.77) GHSRKCNH2MAPTNPY1RNPY2R
SCHEMBL5835194 0.90 GHSR (0.77) GHSRKCNH2MAPTMEN1KMT2A
SCHEMBL5835098 0.90 GHSR (0.77) GHSRKCNH2MAPTNPY1RNPY2R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7115767-B2 Tetraline derivatives as ghrelin receptor modulators ABBOTT LABORATORIES (US) 2006-10-03 US claimed
US-20050014794-A1 Tetraline derivatives as ghrelin receptor modulators ABBVIE INC. 2005-01-20 US claimed
US-7115767-B2 Tetraline derivatives as ghrelin receptor modulators ABBOTT LABORATORIES (US) 2006-10-03 US disclosed
US-20050014794-A1 Tetraline derivatives as ghrelin receptor modulators ABBVIE INC. 2005-01-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050014794-A1 Tetraline derivatives as ghrelin receptor modulators GPR119, GHSR, GIPR GHSR 2/4885KCNH2 3931/4885MAPT 3095/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.